MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
August 4, 2005
Nathan Parmelee
Still a Green Monster Spectacular earnings growth and a strong margin make for a very strong quarter at consumer products company CNS. mark for My Articles similar articles
The Motley Fool
April 29, 2005
W.D. Crotty
CNS Has a Nose for Cash The company that gave us Breathe Rights continues to build a large cash hoard. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 26, 2006
Nathan Parmelee
CNS Is All Stuffed Up The company that gave us Breathe Right nasal strips missed analyst estimates and the stock gets crushed. mark for My Articles similar articles
The Motley Fool
October 9, 2006
Nathan Parmelee
CNS Shareholders Can Breathe Easy CNS will be acquired by GlaxoSmithKline. There should be no bitterness on either side in this deal. CNS shareholders are getting amply rewarded. mark for My Articles similar articles
The Motley Fool
January 21, 2005
W.D. Crotty
CNS Strips for Profits Nasal strip sales soar, and so do the company's third-quarter profits. mark for My Articles similar articles
The Motley Fool
February 9, 2004
Paul Elliott
Small Cap Floating on Air CNS, maker of Breathe Right nasal strips, is a stock I love. The attraction is financial. And CNS's financials are a thing of beauty, starting with a pile of cash -- $46.87 million -- and not a penny of debt. mark for My Articles similar articles
The Motley Fool
October 22, 2004
W.D. Crotty
CNS's Whiff of Fresh Air The company's Breathe Right franchise is a real money machine. Net income of $0.24 a share beat analyst estimates by $0.05 and the top end of the company's guidance. mark for My Articles similar articles
The Motley Fool
November 17, 2005
Nathan Parmelee
Dueling Fools: CNS Bull A large part of the reason this consumer products company's shares have advanced 121% over the last two years is because the company's shares didn't reflect the strong profitability of the business or its growth prospects. mark for My Articles similar articles
The Motley Fool
January 24, 2006
Rich Smith
Foolish Forecast: Simply CNS Analysts believe that CNS will grow at an annualized rate of 18% in the long term. That's tremendous, but perhaps not enough to justify its P/E ratio of 21, or its price-to-free cash flow ratio of 21. mark for My Articles similar articles
The Motley Fool
April 30, 2004
Rick Aristotle Munarriz
CNS "Nose" Best The company that created the Breathe Right nasal strips is apparently doing a few more things right than just breathing. Its stock closed yesterday at just 16 times its median profit target. mark for My Articles similar articles
The Motley Fool
October 10, 2006
Bill Mann
Want to Find Buyout Candidates? Mergers don't always take place on great terms for shareholders, nonetheless, many investors continue to seek out these kinds of situations. It's part of the power of small-cap companies -- often they're the minnows that the big fish seek to make themselves grow. mark for My Articles similar articles
The Motley Fool
October 21, 2004
Rich Smith
Lucent Back in Black Company turns full-year-profitable, but dilution runs rampant. mark for My Articles similar articles
The Motley Fool
November 29, 2004
Rich Duprey
A Patented Challenge to CNS The Patent and Trademark Office is reconsidering two patents of the nasal strips maker. Investors took notice and slapped the company down 8%, which ought to present an opportunity to pick up shares. mark for My Articles similar articles
The Motley Fool
May 19, 2004
Rich Smith
Symantec's Trojan Buyback The software company is raking in the cash and distributing it to insiders. mark for My Articles similar articles
The Motley Fool
December 23, 2004
Tim Beyers
Red Hat Turns Green A big increase in profits is overshadowed by poorer-than-expected guidance. mark for My Articles similar articles
The Motley Fool
December 27, 2005
Nathan Parmelee
Understanding Share Counts How to sort out option exercises, share repurchases, and the different share counts reported. mark for My Articles similar articles
The Motley Fool
November 3, 2006
Smell the Roses at CNS: Fool by Numbers The consumer health-care products maker released second-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
December 29, 2004
Rich Smith
Panning for Gold In an equity universe with thousands of stocks to choose from, how do you sort the "good stuff" from the rubbish? Here are seven easy steps to show you how to tell a possible gem from a probable rock. mark for My Articles similar articles
The Motley Fool
January 25, 2005
Nathan Slaughter
Sara Lee Slimming Down Has the conglomerate, which reduced its second-half outlook, lost its way? Investors should allow for a little more patience as the company works through sluggish conditions. mark for My Articles similar articles
The Motley Fool
June 24, 2004
Nathan Parmelee
CNS Is a Green Monster CNS packs an impressive amount of cash and, even more impressively, keeps piling up the green stuff. mark for My Articles similar articles
The Motley Fool
November 24, 2004
Tom Engle
A Small-Cap Market Beater Medical Action Industries is primed for success. Investors transfixed on earnings and sales growth might miss other signs that the company is growing in value. mark for My Articles similar articles
The Motley Fool
February 8, 2007
Ryan Fuhrmann
Sara Lee's Messy Kitchen The jury is still out on Sara Lee's prospects. The stock is trading just below its 52-week highs, so investors appear comfortable with where the company is heading. mark for My Articles similar articles
The Motley Fool
February 17, 2006
Jim Mueller
Sportsman's Guide Shapes Up Management for the Internet outdoor gear and golf-equipment provider has been doing everything right recently for the company and its shareholders. The stock has risen 60% in the last year, much to shareholders' delight. mark for My Articles similar articles
The Motley Fool
November 17, 2005
W.D. Crotty
Dueling Fools: CNS Bear Rebuttal Do what insiders are doing. Over the last six months, in 19 separate transactions, the consumer products company sold 237,439 shares. There were no purchases. mark for My Articles similar articles
The Motley Fool
December 4, 2006
Ryan Fuhrmann
Heinz Bottles Recent Gains Judging by second-quarter results, it's hard to tell whether renewed management focus and activist shareholder recommendations have in fact taken hold. mark for My Articles similar articles
The Motley Fool
May 8, 2006
Rick Aristotle Munarriz
4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Let's take a closer look at four of the companies that inched their payouts higher this past week. PepsiCo... CNS... etc. mark for My Articles similar articles
The Motley Fool
November 8, 2005
W.D. Crotty
WD-40's Annoying Squeak The consumer products company produces a strong profit in the fourth quarter, but the outlook is clouded. mark for My Articles similar articles
The Motley Fool
January 6, 2006
Rich Smith
Foolish Forecast: WD-40 and Other Numbers Can the grease-meister slide out from under analyst estimates? Investors, take note. mark for My Articles similar articles
The Motley Fool
January 7, 2005
W.D. Crotty
A Big Blast From WD-40 Spray maker announces its first-quarter earnings are up 28.4%. For the coming year, the company expects to earn $1.62 a share -- up 8% from the $1.50 earned last year. mark for My Articles similar articles
The Motley Fool
April 7, 2005
W.D. Crotty
WD-40's Squeaky Wheel WD-40's second-quarter net income falls 15.5%. mark for My Articles similar articles
The Motley Fool
January 10, 2007
Steven Mallas
WD-40 Still Needs Grease Is the company behind the famous brand a viable investment idea right now? mark for My Articles similar articles
The Motley Fool
February 9, 2005
Rich Smith
Hunting Baby Elephants Wouldn't you like to find -- and buy -- tomorrow's 6-ton business behemoths while they're still small? Here's how to do it. mark for My Articles similar articles
The Motley Fool
January 4, 2007
Rich Duprey
Foolish Forecast: WD-40 a Squeaky Wheel? Investors, will it be a slick quarter for WD-40, which is set to report first-quarter 2007 earnings results? mark for My Articles similar articles
The Motley Fool
June 23, 2011
Seth Jayson
One Reason WD-40 May Be Headed for a Slowdown On a trailing-12-month, basis, finished goods inventory was the fastest-growing segment, up 29.7%. That can be a warning sign. mark for My Articles similar articles
The Motley Fool
May 5, 2004
Paul Elliott
An Investor's Worst Enemy As an investor, few things assure you'll go hungry like a board of directors cutting the pie into more and more pieces and handing them out. Excessive share dilution is precisely that. mark for My Articles similar articles
The Motley Fool
May 24, 2007
Chuck Saletta
Dueling Fools: The Knot Bear With a secondary offering, expensive acquisitions, heavy dilution, and no dividend to speak of, The Knot has simply not shown itself worthy of a long-term commitment of capital. mark for My Articles similar articles
The Motley Fool
January 6, 2011
Seth Jayson
Does This Make WD-40 a Buy Today? Here's the current margin snapshot for WD-40 Co. and some of its sector and industry peers and direct competitors. mark for My Articles similar articles
The Motley Fool
April 1, 2005
Rick Aristotle Munarriz
The Fool's Look Ahead Monday: Jos. A. Bank Clothiers produces its fiscal fourth quarter financials... Tuesday: American Greetings discloses its fiscal fourth quarter results... Wednesday: You didn't even know that WD-40 traded publicly?... etc. mark for My Articles similar articles
The Motley Fool
May 25, 2005
Rich Smith
3 Hidden Gems for the Taking Get these stocks before they're hot on Wall Street: Radyne ComStream... Deckers... Portfolio Recovery Associates... mark for My Articles similar articles